At a National Health Council briefing, FDA Commissioner Scott Gottlieb discussed the importance of patients' perspectives for drug development, reviews and prescribing practices. Gottlieb shared his experience of being diagnosed with stage 1 Hodgkin lymphoma in 2006 and how daunting it was even with his physician saying he had more than a 90% chance of a complete cure.
FDA commissioner: Patients' perspectives should be heard
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.